Poulsbo Compounding Pharmacy LLC, dba Cascade Specialty Pharmacy

FDA inspection history across 2 sites, 2019 to 2026

2
Form 483s
1
Warning letter

Every document, by year

  • Form 483
  • Warning letter

2019: one Form 483; 2020: one warning letter; 2026: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2019–20One Form 483 and one warning letter, at Poulsbo, Washington and Washington.
  2. 2019The longest 483 on file: 7 observations over 8 pages at Poulsbo, Washington.
  3. 2026One Form 483, at Poulsbo, Washington.

Cited most

Across all Poulsbo Compounding Pharmacy LLC, dba Cascade Specialty Pharmacy observations on file

The complete Poulsbo Compounding Pharmacy LLC, dba Cascade Specialty Pharmacy file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2026-07-17483 Form 483$99
2020-10-09Warning letter Warning letter$99
2019-04-17483 Form 483$99

FEI number 3015133983 · most recent document Jul 17, 2026

About Poulsbo Compounding Pharmacy LLC, dba Cascade Specialty Pharmacy

How many FDA Form 483s has Poulsbo Compounding Pharmacy LLC, dba Cascade Specialty Pharmacy received?

FDA Intel has 2 Form 483s on file for Poulsbo Compounding Pharmacy LLC, dba Cascade Specialty Pharmacy; the most recent is dated Jul 17, 2026.

When was Poulsbo Compounding Pharmacy LLC, dba Cascade Specialty Pharmacy last inspected by FDA?

The most recent FDA inspection document on file for Poulsbo Compounding Pharmacy LLC, dba Cascade Specialty Pharmacy is a Form 483 dated Jul 17, 2026, for the site in Poulsbo, Washington.

What did FDA cite at Poulsbo Compounding Pharmacy LLC, dba Cascade Specialty Pharmacy?

The regulations cited most in the observations on file for Poulsbo Compounding Pharmacy LLC, dba Cascade Specialty Pharmacy are 21 CFR 211.67 (Equipment cleaning and maintenance), 4 times; 21 CFR 211.113 (Control of microbiological contamination), 3 times; 21 CFR 211.42 (Design and construction features), 3 times.

Has Poulsbo Compounding Pharmacy LLC, dba Cascade Specialty Pharmacy received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Poulsbo Compounding Pharmacy LLC, dba Cascade Specialty Pharmacy; the most recent is dated Oct 9, 2020.